Trial Outcomes & Findings for The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass (NCT NCT01928082)
NCT ID: NCT01928082
Last Updated: 2018-12-10
Results Overview
0 participants were measured because the study was terminated
TERMINATED
PHASE2
1 participants
4 weeks, 8 weeks
2018-12-10
Participant Flow
Participant milestones
| Measure |
Transdermal Estradiol
Transdermal estradiol 0.05 mg/day for 4 weeks, followed by 0.10 mg/day for 4 weeks
Transdermal estradiol: 4 weeks of Vivelle-Dot 0.05 mg/day followed by 4 weeks of Vivelle-Dot 0.10 mg/day
|
|---|---|
|
Overall Study
STARTED
|
1
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
| Measure |
Transdermal Estradiol
Transdermal estradiol 0.05 mg/day for 4 weeks, followed by 0.10 mg/day for 4 weeks
Transdermal estradiol: 4 weeks of Vivelle-Dot 0.05 mg/day followed by 4 weeks of Vivelle-Dot 0.10 mg/day
|
|---|---|
|
Overall Study
Study terminated.
|
1
|
Baseline Characteristics
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 4 weeks, 8 weeksPopulation: 0 participants were analyzed because the study was terminated
0 participants were measured because the study was terminated
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 4 weeks, 8 weeksPopulation: The study was terminated
0 participants were analyzed because the study was terminated
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 4 weeks, 8 weeksPopulation: the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
Not available because the study was terminated
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 4 weeks, 8 weeksPopulation: Not available because the study was terminated
It is not available because the study was terminated
Outcome measures
Outcome data not reported
Adverse Events
Transdermal Estradiol
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place